Perinatal heptachlor exposure increases expression of presynaptic dopaminergic markers in mouse striatum

NeuroToxicology

Volumn 26, Issue 4 SPEC. ISS., 2005, Pages 721-728

  Caudle, W Michael ^a,b   Richardson, Jason R ^a,b   Wang, Minzheng ^a,b   Miller, Gary W ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Developmental neurotoxicity; Dopamine transporter; Heptachlor; Parkinson's disease; Tyrosine hydroxylase; Vesicular monoamine transporter 2

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; AROMATIC LEVO AMINO ACID DECARBOXYLASE; DOPAMINE TRANSPORTER; HEPTACHLOR; TYROSINE 3 MONOOXYGENASE; VESICULAR MONOAMINE TRANSPORTER 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BRAIN REGION; BREEDING; CONFERENCE PAPER; CONTROLLED STUDY; CORPUS STRIATUM; DEVELOPMENTAL STAGE; DISEASE PREDISPOSITION; DOPAMINE BRAIN LEVEL; DOPAMINERGIC ACTIVITY; DOPAMINERGIC NERVE CELL; ENZYME ACTIVITY; FEMALE; GESTATIONAL AGE; LACTATION; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PERINATAL DRUG EXPOSURE; PERINATAL PERIOD; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PROGENY; WEANING;

ANIMALIA; ARACHIS HYPOGAEA;

EID: 23844502622     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2004.09.003     Document Type: Conference Paper

References (44)

1. D.B. Baker, S. Loo, and J. Barker Evaluation of human exposure to the heptachlor epoxide contamination of milk in Hawaii Hawaii Med J 50 1991 108 112
2. M.M. Bradford A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 1976 248 254
3. T.A. Brosenitsch, and D.M. Katz Physiological patterns of electrical stimulation can induce neuronal gene expression by activating N-type calcium channels J Neurosci 21 2001 2571 2579
4. P. Celeda, C.A. Paladini, and J.M. Tepper GABAergic control of rat substantia nigra dopaminergic neurons: role of the globus pallidus and substantia nigra pars reticulata Neuroscience 89 1999 813 825
5. F.M. Corrigan, C.L. Wienburg, R.F. Shore, S.E. Daniel, and D. Mann Organochlorine insecticides in substantia nigra in Parkinson's disease J Toxicol Environ Health 59 2000 229 234
6. D.M. Donovan, L.L. Miner, M.P. Perry, R.S. Revay, L.G. Sharpe, and S. Przedborski Cocaine reward and MPTP toxicity: alteration by regional variant dopamine transporter overexpression Mol Brain Res 73 1999 37 49
7. J.D. Erickson, L.E. Eiden, and B.J. Hoffman Expression cloning of a reserpine-sensitive vesicular monoamine transporter Proc Natl Acad Sci USA 89 1992 10993 10997
8. E.A. Fendick, E. Mather-Mihaich, K.A. Houck, M.B. St. Clair, J.B. Faust, and C.H. Rockwell Ecological toxicology and human health effects of heptachlor Rev Environ Contam Toxicol 111 1990 61 142
9. L. Fleming, J.B. Mann, J. Bean, T. Briggle, and J.R. Sanchez-Ramos Parkinson's disease and brain levels of organochlorine pesticides Ann Neurol 36 1994 100 103
10. F. Fumagalli, R.R. Gainetdinov, K. Valenzan, Y.M. Wang, G.W. Miller, and M.G. Caron Increased methamphetamine toxicity in heterozygote VMAT2 knockout mice J Neurosci 19 1999 2424 2431
11. R.R. Gainetdinov, F. Fumagalli, S.R. Jones, and M.G. Caron Dopamine transporter is required for in vivo MPTP neurotoxicity: evidence from mice lacking the transporter J Neurochem 69 1997 1322 1324
12. R.R. Gainetdinov, F. Fumagalli, Y. Wang, S.R. Jones, G.W. Miller, and M.G. Caron Increased sensitivity to MPTP in heterozygote VMAT2 knockout mice J Neurochem 70 1998 1973 1978
13. O. Giorgi, G. De Montis, M.L. Porceddu, S. Mele, G. Calderini, and G. Toffano Developmental and age-related changes in D1-dopamine receptors and dopamine content in the rat striatum Brain Res 432 1987 283 290
14. B. Giros, and M.G. Caron Molecular characterization of the dopamine transporter Trends Pharmacol Sci 14 1993 43 49
15. W. Gong, D.B. Neill, and J.B. Justice Jr. GABAergic modulation of ventral pallidal dopamine release studied by in vivo microdialysis in the freely moving rat Synapse 29 1998 406 412
16. T.G. Hastings, D.A. Lewis, and M.J. Zigmond Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections Proc Natl Acad Sci USA 93 1996 1956 1961
17. E. Hermanson, B. Joseph, D. Castro, E. Lindqvist, P. Aarnisalo, and A. Wallen Nurr1 regulates dopamine synthesis and storage in MN9D dopamine cells Exp Cell Res 288 2003 324 334
18. M. Jaber, B. Dumartin, C. Sagne, J.W. Haycock, C. Roubert, and B. Giros Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter Eur J Neurosci 11 1999 3499 3511
19. J.A. Javitch, R.O. Blaustein, and S.H. Snyder [3H] mazindol binding associated with dopamine and norepinephrine uptake sites Mol Pharm 26 1984 35 44
20. S.R. Jones, R.R. Gainetdinov, M. Jaber, B. Giros, R.M. Wightman, and M.G. Caron Profound neuronal plasticity in response to inactivation of the dopamine transporter Proc Natl Acad Sci USA 95 1999 4029 4034
21. M.L. Kirby, R.L. Barlow, and J.R. Bloomquist Neurotoxicity of the organochlorine insecticide heptachlor to murine striatal dopaminergic pathways Toxicol Sci 61 2001 100 106
22. M.L. Kirby, R.L. Barlow, and J.R. Bloomquist Selective effects of cyclodiene insecticides on dopamine release in mammalian synaptosomes Toxicol Appl Pharm 181 2002 89 92
23. S.C. Kumer, and K.E. Vrana Intricate regulation of tyrosine hydroxylase activity and gene expression J Neurochem 67 1996 433 462
24. J.M. Lauder, J. Liu, L. Devaud, and A.L. Morrow GABA as a trophic factor for developing monoamine neurons Perspect Dev Neurobiol 5 1998 247 259
25. J. Liu, K.C. Brannen, D.R. Grayson, A.L. Morrow, L.L. Devaud, and J.M. Lauder Prenatal exposure to the pesticide dieldrin or the GABA(A) receptor antagonist bicuculline differentially alters the expression of GABA(A) receptor subunit mRNAs in fetal rat brainstem Dev Neurosci 20 1998 83 92
26. J. Liu, A.L. Morrow, L.L. Devaud, D.R. Grayson, and J.M. Lauder Regulation of GABA(A) receptor subunit mRNA expression by the pesticide dieldrin in embryonic brainstem cultures: a quantitative, competitive reverse transcription-polymerase chain reaction study J Neurosci Res 49 1997 553 645
27. G.W. Miller, C.J. Heilman, J.T. Perez, J.K. Staley, D. Mash, and D.B. Rye Immunohistochemical analysis of dopamine transporter protein in Parkinson's disease Ann Neurol 41 1997 530 539
28. G.W. Miller, J.D. Erickson, J.T. Perez, S.N. Penland, D.C. Mash, and D.B. Rye Immunochemical analysis of vesicular monoamine transporter protein in Parkinson's disease Exp Neurol 156 1999 138 148
29. G.W. Miller, R.R. Gainetdinov, A.I. Levey, and M.G. Caron Dopamine transporters and neuronal injury Trends Pharmacol Sci 20 1999 424 429
30. G.W. Miller, M.L. Kirby, A.I. Levey, and J.R. Bloomquist Heptachlor alters expression and function of dopamine transporters Neurotoxicology 20 1999 631 638
31. T. Narahashi Neuronal ion channels as the target sites for insecticides Pharmacol Toxicol 79 1996 1 14
32. C.A. Paladini, and J.M. Tepper GABA(A) and GABA(B) antagonists differentially affect the firing pattern of substantia nigra dopaminergic neurons in vivo Synapse 32 1999 165 176
33. S. Purkerson-Parker, K.L. McDaniel, and V.C. Moser Dopamine transporter binding in the rat striatum is increased by gestational, perinatal, and adolescent exposure to heptachlor Toxicol Sci 64 2001 216 223
34. A. Priyadarshi, S.A. Kuder, E.A. Schaub, and S. Shrivastava A meta-analysis of Parkinson's disease and exposure to pesticides Neurotoxicology 21 2000 435 440
35. J.R. Richardson, and G.W. Miller Acute exposure to Aroclor 1016 and 1260 differentially affects the dopamine transporter and vesicular monoamine transporter 2 levels Toxicol Lett 148 2004 29 40
36. P. Sacchetti, T.R. Mitchell, J.G. Granneman, and M.J. Bannon Nurr1 enhances transcription of the human dopamine transporter gene through a novel mechanism J Neurochem 76 2001 1565 1572
37. C.J. Schmitt Organochlorine chemical residues in fish from the Mississippi River Basin, 1995 Arch Environ Contam Toxicol 43 2002 81 97
38. I. Shimizu, and C. Prasad Relationship between [3H] mazindol binding to dopamine uptake sites and [3H] dopamine uptake during aging J Neurochem 56 1991 575 579
39. S.M. Smits, T. Ponnio, O.M. Conneely, J.P. Burbach, and M.P. Smidt Involvement of Nurr1 in specifying the neurotransmitter identity of ventral midbrain dopaminergic neurons Eur J Neurosci 18 2003 1731 1738
40. N. Takahashi, L.L. Miner, I. Sora, H. Ujike, R.S. Revay, and V. Kostic VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion and enhanced MPTP toxicity Proc Natl Acad Sci USA 94 1997 9938 9943
41. J.L. Tillerson, W.M. Caudle, M.E. Reveron, and G.W. Miller Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Exp Neurol 178 2002 80 90
42. G.R. Uhl Hypothesis: the role of dopaminergic transporters in selective vulnerability of cells in Parkinson's disease Ann Neurol 43 1998 555 560
43. G.R. Uhl, S. Li, N. Takahashi, K. Itokawa, Z. Lin, and M. Hazama The VMAT2 gene in mice and humans: amphetamine responses, locomotion, cardiac arrhythmias, aging, and vulnerability to dopaminergic toxins FASEB J 14 2000 2459 2465
44. US Department of Agriculture Pesticide data program annual summary calendar 1997 Agricultural Marketing Service, USDA Washington, DC